Clinical Trials
2 trialsNCT00410462 2014-08-08
Brostallicin or Doxorubicin as First-Line Therapy in Treating Patients With Relapsed, Refractory, or Metastatic Soft Tissue Sarcoma
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Unknown
NCT00633165 2010-02-26
SMI-BRS-202
Systems Medicine LLC
Phase 2 Unknown